Inhibition of dopamine release via presynaptic D2 receptors:: Time course and functional characteristics in vivo

被引:211
作者
Benoit-Marand, M
Borrelli, E
Gonon, F
机构
[1] Univ Bordeaux 2, Unite Mixte Rech 5541, CNRS, F-33076 Bordeaux, France
[2] Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France
关键词
dopamine; release; presynaptic inhibition; D2; receptor; in vivo voltammetry; striatum; mouse;
D O I
10.1523/JNEUROSCI.21-23-09134.2001
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Most neurotransmitters inhibit their own release through autoreceptors. However, the physiological functions of these presynaptic inhibitions are still poorly understood, in part because their time course and functional characteristics have not been described in vivo. Dopamine inhibits its own release through D2 autoreceptors. Here, the part played by autoinhibition in the relationship between impulse flow and dopamine release was studied in vivo in real time. Dopamine release was evoked in the striatum of anesthetized mice by electrical stimulation of the medial forebrain bundle and was continuously monitored by amperometry using carbon fiber electrodes. Control experiments performed in mice lacking D2 receptors showed no autoinhibition of dopamine release. In wild-type mice, stimulation at 100 Hz with two to six pulses linearly inhibited further release, whereas single pulses were inefficient. Dopaminergic neurons exhibit two discharge patterns: single spikes forming a tonic activity below 4 Hz and bursts of two to six action potentials at 15 Hz. Stimulation mimicking one burst (four pulses at 15 Hz) promoted extracellular dopamine accumulation and thus inhibited further dopamine release. This autoinhibition was maximal between 150 and 300 msec after stimulation and disappeared within 600 msec. This delayed and prolonged time course is not reflected in extracellular DA availability and thus probably attributable to mechanisms downstream from autoreceptor stimulation. Thus, in physiological conditions, autoinhibition has two important roles. First, it contributes to the attenuation of extracellular dopamine during bursts. Second, autoinhibition elicited by one burst transiently attenuates further dopamine release elicited by tonic activity.
引用
收藏
页码:9134 / 9141
页数:8
相关论文
共 48 条
[1]
AGNETER E, 1994, J PHARMACOL EXP THER, V269, P470
[2]
Tonic and synaptically evoked presynaptic inhibition of sensory input to the rat olfactory bulb via GABAB heteroreceptors [J].
Aroniadou-Anderjaska, V ;
Zhou, FM ;
Priest, CA ;
Ennis, M ;
Shipley, MT .
JOURNAL OF NEUROPHYSIOLOGY, 2000, 84 (03) :1194-1203
[3]
PARKINSONIAN-LIKE LOCOMOTOR IMPAIRMENT IN MICE LACKING DOPAMINE D2 RECEPTORS [J].
BAIK, JH ;
PICETTI, R ;
SAIARDI, A ;
THIRIET, G ;
DIERICH, A ;
DEPAULIS, A ;
LEMEUR, M ;
BORRELLI, E .
NATURE, 1995, 377 (6548) :424-428
[4]
Release and elimination of dopamine in vivo in mice lacking the dopamine transporter:: functional consequences [J].
Benoit-Marand, M ;
Jaber, M ;
Gonon, F .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 (08) :2985-2992
[5]
Synaptic plasticity and physiological interactions between dopamine and glutamate in the striatum [J].
Calabresi, P ;
Pisani, A ;
Centonze, D ;
Bernardi, G .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1997, 21 (04) :519-523
[6]
DIRECT IN-VIVO EVIDENCE THAT D2 DOPAMINE-RECEPTORS CAN MODULATE DOPAMINE UPTAKE [J].
CASS, WA ;
GERHARDT, GA .
NEUROSCIENCE LETTERS, 1994, 176 (02) :259-263
[7]
NONLINEAR RELATIONSHIP BETWEEN IMPULSE FLOW, DOPAMINE RELEASE AND DOPAMINE ELIMINATION IN THE RAT-BRAIN IN-VIVO [J].
CHERGUI, K ;
SUAUDCHAGNY, MF ;
GONON, F .
NEUROSCIENCE, 1994, 62 (03) :641-645
[8]
Increased expression of NGFI-A mRNA in the rat striatum following burst stimulation of the medial forebrain bundle [J].
Chergui, K ;
Svenningsson, P ;
Nomikos, GG ;
Gonon, F ;
Fredholm, BB ;
Svennson, TH .
EUROPEAN JOURNAL OF NEUROSCIENCE, 1997, 9 (11) :2370-2382
[9]
Regulation of depolarizing GABAA receptor-mediated synaptic potentials by synaptic activation of GABAB autoreceptors in the rat hippocampus [J].
Cobb, SR ;
Manuel, NA ;
Morton, RA ;
Gill, CH ;
Collingridge, GL ;
Davies, CH .
NEUROPHARMACOLOGY, 1999, 38 (11) :1723-1732
[10]
Cragg SJ, 1997, J NEUROSCI, V17, P5738